New Price Cuts on Anti-Cancer Drugs: What You Need to Know

The National Pharmaceutical Pricing Authority has announced significant reductions in the Maximum Retail Prices of 1,364 anti-cancer medications, projected to save consumers around Rs 3,540.38 crore annually. With price cuts exceeding 50% for many brands, this initiative aims to make essential treatments more affordable. Consumers can verify prices through various platforms and report any overcharging issues. Read on to learn more about these changes and how they affect you.

By Narendra Chaudhary Nov 9, 2026, 13:11 IST

Significant Price Reductions for Anti-Cancer Medications

New Delhi: Starting Monday, the revised Maximum Retail Prices (MRPs) for 1,364 anti-cancer medications have been implemented, which is expected to save consumers approximately Rs 3,540.38 crore each year, as stated in an official announcement.

The National Pharmaceutical Pricing Authority (NPPA), operating under the Department of Pharmaceuticals, has set trade margin limits on the MRPs of 137 anti-cancer drugs. This decision follows recommendations made by an Expert Committee from the Directorate General of Health Services (DGHS) on October 17, 2026.

As of November 8, 2026, 85 pharmaceutical firms have updated the MRPs for 1,364 anti-cancer formulations across 121 different drugs.

Notably, price reductions exceeding 50% have been observed for 679 brands, with the most significant reduction reaching 96.45%, according to the Ministry of Chemicals and Fertilizers: Department of Pharmaceuticals.

The ministry has emphasized that no pharmacy or hospital is allowed to charge more than the newly established MRPs.

Consumers can check the prices of medications through the revised MRP printed on the packaging, the 'Pharma Sahi Daam' mobile app, or by visiting the official NPPA website.

In case of overcharging or other pricing concerns, consumers can file complaints via the Pharma Jan Samadhan portal or reach out to the NPPA helpline at 1800-111-255.